HI
ELV icon

Harrington Investments’s Elevance Health ELV Stock Holding History

Harrington Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100
Closed -$27K – 94
2018
Q3 		$27K Hold
100
– – 0.02% 111
2018
Q2 		$24K Hold
100
– – 0.02% 112
2018
Q1 		$22K Buy
+100
New +$23.5K 0.02% 113

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harrington Investments's ELV Position: Q4 2018 in Review

Harrington Investments sold out of Elevance Health (ELV) in Q4 2018, closing a stake of 100 shares — an estimated $27K sold.

Harrington Investments first reported a position in ELV in Q1 2018 and held it in 3 quarters. The position peaked at $27K in Q3 2018. 997 funds tracked by Wall St. Rank hold ELV as of Q4 2018.

  • Harrington Investments reported no remaining Elevance Health position as of Q4 2018 after selling out during the quarter.
  • Harrington Investments sold 100 Elevance Health shares in Q4 2018, an estimated $27K.
  • Harrington Investments first reported a position in Elevance Health in Q1 2018 and held it in 3 quarters.
  • Harrington Investments's Elevance Health position peaked at $27K in Q3 2018.
  • 997 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.

Based on Harrington Investments's 13F filing for Q4 2018, filed 1 Feb 2019.